MedTrace Logo

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

NCT01805323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2019-04-17

Study results available
· View outcomes & findings →

Summary

This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.

Conditions

  • Macular Edema

Interventions

DRUG

Dexamethasone Intravitreal Implant

Dexamethasone Intravitreal Implant (OZURDEX®) previously administered according to general clinical practice.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-01
Primary Completion
2013-04-15
Completion
2013-04-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805323 on ClinicalTrials.gov